Kornhauser, D
Bristol-Myers Squibb (United States)
2 papers on CoChat
Most cited papers
- Verified
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
Komoroski, B., Vachharajani, N., Feng, Y., Li, L., Kornhauser, D., & Pfister, M. (2009) · Clinical Pharmacology & Therapeutics
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 396
- Verified
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Komoroski, B., Vachharajani, N., Boulton, D., Kornhauser, D., Geraldes, M., Li, L., & Pfister, M. (2009) · Clinical Pharmacology & Therapeutics
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 350
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free